Table 3.
Available structures of LRRC8 in 2021
| Structure | Functional state | PDB code | Species | Oligomeric state | Solubilization conditions | Freezing buffer conditions | Reference |
|---|---|---|---|---|---|---|---|
| LRRC8A 4.4 Å | Not commented on | 6DJB | Homo sapiens | hexamer | 20 mM Tris pH 8, 150 mM NaCl, 1% DMNG, 2 mg/mL iodoacetamide, and EDTA-free protease inhibitor cocktail | 20 mM Tris pH 8, 150 mM NaCl, 0.05% digitonin, and EDTA-free protease inhibitor cocktail | Kefauver et al., 2018 |
| LRRC8A 4.25 Å | Suggestion that the channel may be open but authors state they can not precisely define open/cosed states on the basis of this structure | 5ZSU | Homo sapiens | hexamer | 50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM DTT, 1% digitonin | 50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM DTT, 0.1% digitonin | Kasuya et al., 2018 |
| LRRC8A 4.18 Å | Apo-LRRC8A in a constricted state | 6O00 | Mus musculus | hexamer | A 10%/2% solution of DDM/CHS was dissolved and clarified by bath sonication in 200 mM HEPES pH 8 prior to addition to the solubilisation buffer. 50 mM HEPES, 150 mM KCl, 1 mM EDTA, 1% DDM, 0.2% CHS, final pH 7.4. | 20 mM HEPES, 150 mM KCl, 1 mM EDTA pH 7.4, POPC, MSP2N2 | Kern et al., 2019 |
| LRRC8A-refined against 5.01 Å map | Authors suggest that the high salt conditions in the freezing buffer favor a closed conformation | 6G9L | Mus musculus | hexamer | 25 mM Tris-HCl, pH 8.5, 250 mM NaCl, 3% digitonin,50 μg ml−1 DNase, 50 μg ml−1 RNase A and protease inhibitors | 25 mM Tris-HCl pH 8.5, 250 mM NaCl, 0.12% digitonin | Deneka and Sawicka et al., 2018 |
| LRRC8A-refined against 4.25 Å map | Authors suggest that the high salt conditions in the freezing buffer favor a closed conformation | 6G9O | Mus musculus | hexamer | 25 mM Tris-HCl, pH 8.5, 250 mM NaCl, 3% digitonin,50 μg ml−1 DNase, 50 μg ml−1 RNase A and protease inhibitors | 25 mM Tris-HCl pH 8.5, 250 mM NaCl, 0.12% digitonin | Deneka and Sawicka et al., 2018 |
| LRRC8A-pore domain 3.66 Å | Authors suggest that the high salt conditions in the freezing buffer favor a closed conformation | 6G8Z | Mus musculus | hexamer | 25 mM Tris-HCl, pH 8.5, 250 mM NaCl, 3% digitonin,50 μg ml−1 DNase, 50 μg ml−1 RNase A and protease inhibitors | 25 mM Tris-HCl pH 8.5, 250 mM NaCl, 0.12% digitonin | Deneka and Sawicka et al., 2018 |
| LRRC8A-LRR domain 1.80 Å (X-ray structure) | n/a | 6FNW | Mus musculus | protomer | 10 mM Tris pH 9.4, 200 mM NaCl, 2% DDM, 50 μg ml−1 DNase, protease inhibitors | The protein was polished on SEC in 10 mM Tris pH 9.4, 200 mM NaCl, 0.1% CHAPS and then supplemented with 0.5% CHAPS and 1 mM tris(2-carboxyethyl)phosphine prior to crystallization in 0.1 M Bis-Tris propane pH 8.5, 0.2 M sodium malonate and 20% PEG3350 | Deneka and Sawicka et al., 2018 |
| LRRC8A-DCPIB 3.21 Å | Constricted state | 6NZW | Mus musculus | hexamer | A 10%/2% solution of DDM/CHS was dissolved and clarified by bath sonication in 200 mM HEPES pH 8 prior to addition to the solubilisation buffer. 50 mM HEPES, 150 mM KCl, 1 mM EDTA, 1% DDM, 0.2% CHS, final pH 7.4. | 20 mM HEPES, 150 mM KCl, 1 mM EDTA pH 7.4, POPC, MSP1E3D1. 100 μM of DCPIB was added prior to freezing. | Kern et al., 2019 |
| LRRC8A-DCPIB 3.32 Å | Expanded state | 6NZZ | Mus musculus | hexamer | A 10%/2% solution of DDM/CHS was dissolved and clarified by bath sonication in 200 mM HEPES pH 8 prior to addition to the solubilisation buffer. 50 mM HEPES, 150 mM KCl, 1 mM EDTA, 1% DDM, 0.2% CHS, final pH 7.4. | 20 mM HEPES, 150 mM KCl, 1 mM EDTA pH 7.4, POPC, MSP1E3D1. 100 μM of DCPIB was added prior to freezing. | Kern et al., 2019 |
| LRRC8D 4.36 Å | Undetermined. Some suggestion that the channel may be in an open conformation | 6M04 | Homo sapiens | hexamer | 50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM DTT, 1% digitonin | 50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM DTT, and 0.1% digitonin | Nakamura et al., 2020 |
| LRRC8A/C heteromer | n/a | n/a (7.94 Å map) | Mus musculus | hexamer | 25 mM Tris-HCl, pH 8.5, 250 mM NaCl, 3% digitonin,50 μg ml−1 DNase, 50 μg ml−1 RNase A and protease inhibitors | 25 mM Tris-HCl pH 8.5, 250 mM NaCl, 0.12% digitonin | Deneka and Sawicka et al., 2018 |